0000878088-11-000078.txt : 20111219 0000878088-11-000078.hdr.sgml : 20111219 20111219144200 ACCESSION NUMBER: 0000878088-11-000078 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20111215 FILED AS OF DATE: 20111219 DATE AS OF CHANGE: 20111219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NORDMANN RONALD M CENTRAL INDEX KEY: 0001189790 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-10827 FILM NUMBER: 111268986 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PAR PHARMACEUTICAL COMPANIES, INC. CENTRAL INDEX KEY: 0000878088 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 223122182 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 BUSINESS PHONE: 201-802-4000 MAIL ADDRESS: STREET 1: 300 TICE BOULEVARD CITY: WOODCLIFF LAKE STATE: NJ ZIP: 07677 FORMER COMPANY: FORMER CONFORMED NAME: PHARMACEUTICAL RESOURCES INC DATE OF NAME CHANGE: 19940526 4 1 primary_doc.xml PRIMARY DOCUMENT X0304 4 2011-12-15 0 0000878088 PAR PHARMACEUTICAL COMPANIES, INC. PRX 0001189790 NORDMANN RONALD M C/O PAR PHARMACEUTICAL COMPANIES INC. 300 TICE BLVD. WOODCLIFF LAKE NJ 07677 1 0 0 0 Common Stock 2011-12-15 4 M 0 2500 29.9 A 6500 D Common Stock 2011-12-15 4 S 0 200 32.5007 D 6300 D Common Stock 2011-12-15 4 S 0 2200 32.5 D 4100 D Common Stock 2011-12-15 4 S 0 100 32.502 D 4000 D Common Stock, Option to buy 29.9 2011-12-15 4 M 0 2500 0 D 2003-01-08 2012-01-07 Common Stock 2500 0 D Mr. Nordmann was granted an option to purchase 2,500 shares of Common Stock under the Company's 1997 Directors Stock and Deferred Fee Plan on January 8, 2002, all of which vested on January 8, 2003. The expiration date of this option is January 7, 2012. LIMITED POWER OF ATTORNEY: KNOW ALL MEN BY THESE PRESENTS, that the undersigned does hereby constitute and appoint MARIAN E. GUSTAFSON with full power to act, as his/her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him/her and in his/her name, place and stead, in any and all capacities, and to do any and all acts and things in his/her name and on his/her behalf, to execute any and all documents and instruments, which said attorney-in-fact may deem necessary or advisable to enable him/her to comply with the reporting requirements pursuant to Section 16 of the Securities Exchange Act of 1934, as amended, including but not limited to Form 4-Statement of Changes in Beneficial Ownership and Form 5-Annual Statement of Changes in Beneficial Ownership, relating to his/her ownership in Par Pharmaceutical Companies, Inc. (the "Company") for the period October 1, 2011 through and including September 30, 2012; and to file the same, and all other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done as fully to all intents and purposes as the undersigned might or could do in person, hereby ratifying and confirming all that the said attorney-in-fact and agent may lawfully do or cause to be done by virtue thereof. /s/ Ronald M. Nordmann Dated: September 9, 2011 /s/ Marian E. Gustafson for Ronald M. Nordmann 2011-12-19